384 related articles for article (PubMed ID: 20107166)
1. The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model.
Fang J; Fang D; Silver PB; Wen F; Li B; Ren X; Lin Q; Caspi RR; Su SB
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3092-9. PubMed ID: 20107166
[TBL] [Abstract][Full Text] [Related]
2. Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity.
Su SB; Silver PB; Grajewski RS; Agarwal RK; Tang J; Chan CC; Caspi RR
J Immunol; 2005 Nov; 175(10):6303-10. PubMed ID: 16272281
[TBL] [Abstract][Full Text] [Related]
3. Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9.
Hölscher C; Reiling N; Schaible UE; Hölscher A; Bathmann C; Korbel D; Lenz I; Sonntag T; Kröger S; Akira S; Mossmann H; Kirschning CJ; Wagner H; Freudenberg M; Ehlers S
Eur J Immunol; 2008 Mar; 38(3):680-94. PubMed ID: 18266299
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 3 ligand polyinosinic:polycytidylic acid enhances autoimmune disease in a retinal autoimmunity model.
Ren X; Zhou H; Li B; Su SB
Int Immunopharmacol; 2011 Jun; 11(6):769-73. PubMed ID: 21296697
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response.
Jones LS; Rizzo LV; Agarwal RK; Tarrant TK; Chan CC; Wiggert B; Caspi RR
J Immunol; 1997 Jun; 158(12):5997-6005. PubMed ID: 9190954
[TBL] [Abstract][Full Text] [Related]
6. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
[TBL] [Abstract][Full Text] [Related]
7. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis.
Tarrant TK; Silver PB; Chan CC; Wiggert B; Caspi RR
J Immunol; 1998 Jul; 161(1):122-7. PubMed ID: 9647215
[TBL] [Abstract][Full Text] [Related]
8. Role for MyD88, TLR2 and TLR9 but not TLR1, TLR4 or TLR6 in experimental autoimmune encephalomyelitis.
Miranda-Hernandez S; Gerlach N; Fletcher JM; Biros E; Mack M; Körner H; Baxter AG
J Immunol; 2011 Jul; 187(2):791-804. PubMed ID: 21685327
[TBL] [Abstract][Full Text] [Related]
9. The role of TLR4 in photoreceptor {alpha}a crystallin upregulation during early experimental autoimmune uveitis.
Saraswathy S; Nguyen AM; Rao NA
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3680-6. PubMed ID: 20207969
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
[TBL] [Abstract][Full Text] [Related]
11. Interphotoreceptor retinoid-binding protein (IRBP)-deficient C57BL/6 mice have enhanced immunological and immunopathogenic responses to IRBP and an altered recognition of IRBP epitopes.
Avichezer D; Liou GI; Chan CC; Lewis GM; Wiggert B; Donoso LA; Nickerson JM; Crawford MA; Caspi RR
J Autoimmun; 2003 Nov; 21(3):185-94. PubMed ID: 14599843
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis.
Tarrant TK; Silver PB; Wahlsten JL; Rizzo LV; Chan CC; Wiggert B; Caspi RR
J Exp Med; 1999 Jan; 189(2):219-30. PubMed ID: 9892605
[TBL] [Abstract][Full Text] [Related]
13. Abrogation of anti-retinal autoimmunity in IL-10 transgenic mice due to reduced T cell priming and inhibition of disease effector mechanisms.
Agarwal RK; Horai R; Viley AM; Silver PB; Grajewski RS; Su SB; Yazdani AT; Zhu W; Kronenberg M; Murray PJ; Rutschman RL; Chan CC; Caspi RR
J Immunol; 2008 Apr; 180(8):5423-9. PubMed ID: 18390724
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
[TBL] [Abstract][Full Text] [Related]
15. Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses.
Grajewski RS; Hansen AM; Agarwal RK; Kronenberg M; Sidobre S; Su SB; Silver PB; Tsuji M; Franck RW; Lawton AP; Chan CC; Caspi RR
J Immunol; 2008 Oct; 181(7):4791-7. PubMed ID: 18802082
[TBL] [Abstract][Full Text] [Related]
16. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
[TBL] [Abstract][Full Text] [Related]
17. Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response.
Wandu WS; Tan C; Ogbeifun O; Vistica BP; Shi G; Hinshaw SJ; Xie C; Chen X; Klinman DM; Cai H; Gery I
PLoS One; 2015; 10(6):e0128906. PubMed ID: 26067490
[TBL] [Abstract][Full Text] [Related]
18. Ex-vivo tolerogenic F4/80⁺ antigen-presenting cells (APC) induce efferent CD8⁺ regulatory T cell-dependent suppression of experimental autoimmune uveitis.
Hsu SM; Mathew R; Taylor AW; Stein-Streilein J
Clin Exp Immunol; 2014 Apr; 176(1):37-48. PubMed ID: 24266626
[TBL] [Abstract][Full Text] [Related]
19. Parental Uveitis Influences Offspring With an Increased Susceptibility to the Experimental Autoimmune Uveitis.
Yin G; Zeng W; Hu K; Gao J; Liu J; Chen Y; Chen F
Front Immunol; 2020; 11():1053. PubMed ID: 32612602
[No Abstract] [Full Text] [Related]
20. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.
Feng CG; Scanga CA; Collazo-Custodio CM; Cheever AW; Hieny S; Caspar P; Sher A
J Immunol; 2003 Nov; 171(9):4758-64. PubMed ID: 14568952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
